LUNGMAP: A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)

Title
A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)
Principal Investigator
Almubarak, Mohammed
Phase
NA
Age Group
Adult
Applicable Disease Sites
Lung Cancer
Participating Institutions
Berkeley Medical Center
Camden Clark Medical Center
Mary Babb Randolph Cancer Center
United Hospital Center
Wheeling Hospital
Contacts
Sabrina Rexroad, RN
Research Nurse
Email:
Valli White, RN
Research Nurse
Phone: +1 304-264-1220
Email:
Maher Kali, MD
Clinical Research Specialist-WVUCI
Phone: +1 304-243-7045
Email:
Layla Tannoury
Clinical Research Specialist
Phone: +1 304-424-2585
Email:
Nnennaya Opara
Clinical Research Specialist
Phone: +1 681-342-1000
Email:
Rachel Harper
Clinical Research Specialist
Phone: +1 304-293-6066
Email:

View on ClinicalTrials.gov